These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16341131)

  • 1. The surgical management of chronic hypotony due to uveitis.
    Liu DT; Li CL; Lee VY
    Eye (Lond); 2006 Dec; 20(12):1373-4; author reply 1373. PubMed ID: 16341131
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic prephthisical ocular hypotony treated by intravitreal triamcinolone acetonide.
    Jonas JB; Vossmerbaeumer U; Kamppeter BA
    Acta Ophthalmol Scand; 2004 Oct; 82(5):637. PubMed ID: 15453876
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Triamcinolone acetonide in ocular therapeutics.
    Rishi P; Sharma T; Rishi E
    Surv Ophthalmol; 2008; 53(2):184; author reply 184. PubMed ID: 18348883
    [No Abstract]   [Full Text] [Related]  

  • 4. Surgery for hypotony in patients with juvenile idiopathic arthritis-associated uveitis.
    Yu EN; Paredes I; Foster CS
    Ocul Immunol Inflamm; 2007; 15(1):11-7. PubMed ID: 17365801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of uveitis-associated refractory ocular hypotony with topical ibopamine].
    Windisch BK; Iliev ME
    Klin Monbl Augenheilkd; 2006 May; 223(5):422-4. PubMed ID: 16705521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triamcinolone acetonide in ocular therapeutics.
    Jermak CM; Dellacroce JT; Heffez J; Peyman GA
    Surv Ophthalmol; 2007; 52(5):503-22. PubMed ID: 17719372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The surgical management of chronic hypotony due to uveitis.
    de Smet MD; Gunning F; Feenstra R
    Eye (Lond); 2005 Jan; 19(1):60-4. PubMed ID: 15319784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical ibopamine in the treatment of chronic ocular hypotony attributable to vitreoretinal surgery, uveitis, or penetrating trauma.
    Ugahary LC; Ganteris E; Veckeneer M; Cohen AC; Jansen J; Mulder PG; van Meurs JC
    Am J Ophthalmol; 2006 Mar; 141(3):571-3. PubMed ID: 16490513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel use of reticulated hyaluronic acid (Healaflow) for hypotony eyes in patients with uveitis.
    Stead RE; Juma Z; Turner S; Jones LD; Sung VC
    Br J Ophthalmol; 2016 Jun; 100(6):727-30. PubMed ID: 27016504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypotony maculopathy in a patient with HLA-B27-associated uveitis.
    Roe R; Branco BC; Cunningham ET
    Ocul Immunol Inflamm; 2008; 16(3):107-8. PubMed ID: 18569798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypotony in patients with uveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial.
    Sen HN; Drye LT; Goldstein DA; Larson TA; Merrill PT; Pavan PR; Sheppard JD; Burke A; Srivastava SK; Jabs DA;
    Ocul Immunol Inflamm; 2012 Apr; 20(2):104-12. PubMed ID: 22409563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ibopamine treatment in chronic hypotony secondary to long-lasting uveitis. A case report.
    Pivetti-Pezzi P; Da Dalt S; La Cava M; Pinca M; De Gregorio F; Virno M
    Eur J Ophthalmol; 2000; 10(4):332-4. PubMed ID: 11192843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal and orbital floor triamcinolone acetonide injections in noninfectious uveitis: a comparative study.
    Roesel M; Gutfleisch M; Heinz C; Heimes B; Zurek-Imhoff B; Heiligenhaus A
    Ophthalmic Res; 2009; 42(2):81-6. PubMed ID: 19478546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic options for a 53-year-old black woman with concomitant glaucoma, uveitis, and cataract.
    Jonas JB
    J Glaucoma; 2001 Aug; 10(4):364. PubMed ID: 11558825
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypotony in uveitis: an overview of medical and surgical management.
    Testi I; Calcagni A; Barton K; Gooch J; Petrushkin H
    Br J Ophthalmol; 2023 Nov; 107(12):1765-1770. PubMed ID: 36575621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of intraoperative intravitreal injection of triamcinolone acetonide injection after phacoemulsification in cases of uveitic cataract.
    Dada T; Dhawan M; Garg S; Nair S; Mandal S
    J Cataract Refract Surg; 2007 Sep; 33(9):1613-8. PubMed ID: 17720079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pros and cons of intravitreal triamcinolone injections for uveitis and inflammatory cystoid macular edema.
    van Kooij B; Rothova A; de Vries P
    Ocul Immunol Inflamm; 2006 Apr; 14(2):73-85. PubMed ID: 16597536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular hypotony: a review.
    Fine HF; Biscette O; Chang S; Schiff WM
    Compr Ophthalmol Update; 2007; 8(1):29-37. PubMed ID: 17394757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.
    Jonas JB
    Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Appraisal and management of ocular hypotony and glaucoma associated with uveitis.
    Tran VT; Mermoud A; Herbort CP
    Int Ophthalmol Clin; 2000; 40(2):175-203. PubMed ID: 10791265
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.